Gene · 833
Papers4,113
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
1,001 to 1,020 of 4,113
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Combined targeting of soluble latent TGF-ß and a solid tumor-associated antigen with adapter CAR T cells. | Oncoimmunology | 2022 | 36387056 | PubTator, text mining | PubMed |
| Neoantigen-specific TCR-T cell-based immunotherapy for acute myeloid leukemia. | Exp Hematol Oncol | 2022 | 36384590 | PubTator, text mining | PubMed |
| HLA-A∗02-gated safety switch for cancer therapy has exquisite specificity for its allelic target antigen. | Mol Ther Oncolytics | 2022 | 36381658 | PubTator, text mining | PubMed |
| Penile cancer: Updates in systemic therapy. | Asian J Urol | 2022 | 36381603 | PubTator, text mining | PubMed |
Chimeric antigen receptor T-cell therapy targeting a MAGE A4 peptide and HLA-A*02:01 complex for unresectable advanced or recurrent solid cancer: protocol for a multi-institutional phase 1 clinical trial. | BMJ Open | 2022 | 36375974 | PubTator, text mining | PubMed |
| Chimeric Antigen Receptor T-Cell Therapy: What We Expect Soon. | Int J Mol Sci | 2022 | 36362130 | PubTator, text mining | PubMed |
| An Innovative PTD-IVT-mRNA Delivery Platform for CAR Immunotherapy of ErbB(+) Solid Tumor Neoplastic Cells. | Biomedicines | 2022 | 36359405 | PubTator, text mining | PubMed |
| Role of CAR T Cell Metabolism for Therapeutic Efficacy. | Cancers (Basel) | 2022 | 36358860 | PubTator, text mining | PubMed |
| Role of Immunotherapy in the Treatment of Cancer: A Systematic Review. | Cancers (Basel) | 2022 | 36358624 | PubTator, text mining | PubMed |
| Preclinical and clinical studies of CAR-NK-cell therapies for malignancies. | Front Immunol | 2022 | 36353643 | PubTator, text mining | PubMed |
| Advancing mRNA technologies for therapies and vaccines: An African context. | Front Immunol | 2022 | 36353641 | PubTator, text mining | PubMed |
| Pre-clinical efficacy of CD20-targeted chimeric antigen receptor T cells for non-Hodgkin's lymphoma. | Discov Oncol | 2022 | 36352168 | PubTator, text mining | PubMed |
| Switchable targeting of solid tumors by BsCAR T cells. | Proc Natl Acad Sci U S A | 2022 | 36343224 | PubTator, text mining | PubMed |
| Advances in CAR T-cell therapy in bile duct, pancreatic, and gastric cancers. | Front Immunol | 2022 | 36341440 | PubTator, text mining | PubMed |
| The role of sulfur compounds in chronic obstructive pulmonary disease. | Front Mol Biosci | 2022 | 36339716 | PubTator, text mining | PubMed |
| Ferroptosis: A potential target for the intervention of intervertebral disc degeneration. | Front Endocrinol (Lausanne) | 2022 | 36339421 | PubTator, text mining | PubMed |
| Construction of the prognostic signature of alternative splicing revealed the prognostic predictor and immune microenvironment in head and neck squamous cell carcinoma. | Front Genet | 2022 | 36338975 | PubTator, text mining | PubMed |
| A novel 10-gene ferroptosis-related prognostic signature in acute myeloid leukemia. | Front Oncol | 2022 | 36338716 | PubTator, text mining | PubMed |
| Intersection of stem cell biology and engineering towards next generation in vitro models of human fibrosis. | Front Bioeng Biotechnol | 2022 | 36338120 | PubTator, text mining | PubMed |
| Supportive Care for Patients with Lymphoma Undergoing CAR-T-cell Therapy: the Advanced Practice Provider's Perspective. | Curr Oncol Rep | 2022 | 36336769 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/833/papers?page=51